Global Adoptive Cellular Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Global Adoptive Cellular Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Adoptive Cellular Immunotherapy Market Overview
1.1 Product Overview and Scope of Adoptive Cellular Immunotherapy
1.2 Classification of Adoptive Cellular Immunotherapy by Types
1.2.1 Global Adoptive Cellular Immunotherapy Revenue Comparison by Types (2019-2024)
1.2.2 Global Adoptive Cellular Immunotherapy Revenue Market Share by Types in 2018
1.2.3 TIL
1.2.4 LAK
1.2.5 CAR-T
1.2.6 TCR-T
1.2.7 CIK
1.2.8 NK
1.2.9 DC
1.2.10 Other
1.3 Global Adoptive Cellular Immunotherapy Market by Application
1.3.1 Global Adoptive Cellular Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Cancer Hospital
1.3.4 Centers for Disease Control and Prevention
1.3.5 Rehabilitation Center
1.3.6 Other
1.4 Global Adoptive Cellular Immunotherapy Market by Regions
1.4.1 Global Adoptive Cellular Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adoptive Cellular Immunotherapy Status and Prospect (2014-2024)
1.5 Global Market Size of Adoptive Cellular Immunotherapy (2014-2024)
2 Manufacturers Profiles
2.1 Amgen Inc
2.1.1 Business Overview
2.1.2 Adoptive Cellular Immunotherapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.2 Autolus Therapeutics Plc
2.2.1 Business Overview
2.2.2 Adoptive Cellular Immunotherapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.3 Beijing Immunochina Medical Science & Technology Co Ltd
2.3.1 Business Overview
2.3.2 Adoptive Cellular Immunotherapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bellicum Pharmaceuticals Inc
2.4.1 Business Overview
2.4.2 Adoptive Cellular Immunotherapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bristol-Myers Squibb Co
2.5.1 Business Overview
2.5.2 Adoptive Cellular Immunotherapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.6 bluebird bio Inc
2.6.1 Business Overview
2.6.2 Adoptive Cellular Immunotherapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.7 CARsgen Therapeutics Ltd
2.7.1 Business Overview
2.7.2 Adoptive Cellular Immunotherapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corp
2.8.1 Business Overview
2.8.2 Adoptive Cellular Immunotherapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.9 Cell Medica Ltd
2.9.1 Business Overview
2.9.2 Adoptive Cellular Immunotherapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.10 Cellular Biomedicine Group Inc
2.10.1 Business Overview
2.10.2 Adoptive Cellular Immunotherapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celularity Inc
2.11.1 Business Overview
2.11.2 Adoptive Cellular Immunotherapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.12 Celyad SA
2.12.1 Business Overview
2.12.2 Adoptive Cellular Immunotherapy Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.13 Daiichi Sankyo Co Ltd
2.13.1 Business Overview
2.13.2 Adoptive Cellular Immunotherapy Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.14 Fosun Pharmaceutical AG
2.14.1 Business Overview
2.14.2 Adoptive Cellular Immunotherapy Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.15 Gilead Sciences Inc
2.15.1 Business Overview
2.15.2 Adoptive Cellular Immunotherapy Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.16 Guangzhou Anjie Biomedical Technology Co Ltd
2.16.1 Business Overview
2.16.2 Adoptive Cellular Immunotherapy Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.17 Hangzhou Converd Co Ltd
2.17.1 Business Overview
2.17.2 Adoptive Cellular Immunotherapy Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.18 Hebei Senlang Biotechnology Inc Ltd
2.18.1 Business Overview
2.18.2 Adoptive Cellular Immunotherapy Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.19 HRAIN Biotechnology Co Ltd
2.19.1 Business Overview
2.19.2 Adoptive Cellular Immunotherapy Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.20 Juno Therapeutics Inc
2.20.1 Business Overview
2.20.2 Adoptive Cellular Immunotherapy Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.21 Kite Pharma Inc
2.21.1 Business Overview
2.2.2 Adoptive Cellular Immunotherapy Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.22 Nanjing Legend Biotech Co Ltd
2.22.1 Business Overview
2.22.2 Adoptive Cellular Immunotherapy Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.23 NantKwest Inc
2.23.1 Business Overview
2.23.2 Adoptive Cellular Immunotherapy Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.24 Nkarta Inc
2.24.1 Business Overview
2.24.2 Adoptive Cellular Immunotherapy Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.25 Novartis AG
2.25.1 Business Overview
2.25.2 Adoptive Cellular Immunotherapy Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.26 Ono Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Adoptive Cellular Immunotherapy Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
2.27.1 Business Overview
2.27.2 Adoptive Cellular Immunotherapy Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.28 Sorrento Therapeutics Inc
2.28.1 Business Overview
2.28.2 Adoptive Cellular Immunotherapy Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
2.29 Takara Bio Inc
2.29.1 Business Overview
2.29.2 Adoptive Cellular Immunotherapy Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
3 Global Adoptive Cellular Immunotherapy Market Competition, by Players
3.1 Global Adoptive Cellular Immunotherapy Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Adoptive Cellular Immunotherapy Players Market Share
3.2.2 Top 10 Adoptive Cellular Immunotherapy Players Market Share
3.3 Market Competition Trend
4 Global Adoptive Cellular Immunotherapy Market Size by Regions
4.1 Global Adoptive Cellular Immunotherapy Revenue and Market Share by Regions
4.2 North America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.3 Europe Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.5 South America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
5 North America Adoptive Cellular Immunotherapy Revenue by Countries
5.1 North America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
5.2 USA Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
5.3 Canada Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
5.4 Mexico Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6 Europe Adoptive Cellular Immunotherapy Revenue by Countries
6.1 Europe Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
6.2 Germany Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.3 UK Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.4 France Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.5 Russia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
6.6 Italy Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Adoptive Cellular Immunotherapy Revenue by Countries
7.1 Asia-Pacific Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
7.2 China Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.3 Japan Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.4 Korea Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.5 India Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
8 South America Adoptive Cellular Immunotherapy Revenue by Countries
8.1 South America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
8.2 Brazil Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
8.3 Argentina Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
8.4 Colombia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Adoptive Cellular Immunotherapy by Countries
9.1 Middle East and Africa Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
9.2 Saudi Arabia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.3 UAE Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.4 Egypt Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.5 Nigeria Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
9.6 South Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
10 Global Adoptive Cellular Immunotherapy Market Segment by Type
10.1 Global Adoptive Cellular Immunotherapy Revenue and Market Share by Type (2014-2019)
10.2 Global Adoptive Cellular Immunotherapy Market Forecast by Type (2019-2024)
10.3 TIL Revenue Growth Rate (2014-2024)
10.4 LAK Revenue Growth Rate (2014-2024)
10.5 CAR-T Revenue Growth Rate (2014-2024)
10.6 TCR-T Revenue Growth Rate (2014-2024)
10.7 CIK Revenue Growth Rate (2014-2024)
10.8 NK Revenue Growth Rate (2014-2024)
10.9 DC Revenue Growth Rate (2014-2024)
10.10 Other Revenue Growth Rate (2014-2024)
11 Global Adoptive Cellular Immunotherapy Market Segment by Application
11.1 Global Adoptive Cellular Immunotherapy Revenue Market Share by Application (2014-2019)
11.2 Adoptive Cellular Immunotherapy Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Cancer Hospital Revenue Growth (2014-2019)
11.5 Centers for Disease Control and Prevention Revenue Growth (2014-2019)
11.6 Rehabilitation Center Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Adoptive Cellular Immunotherapy Market Size Forecast (2019-2024)
12.1 Global Adoptive Cellular Immunotherapy Market Size Forecast (2019-2024)
12.2 Global Adoptive Cellular Immunotherapy Market Forecast by Regions (2019-2024)
12.3 North America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.4 Europe Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.6 South America Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Adoptive Cellular Immunotherapy Picture
Table Product Specifications of Adoptive Cellular Immunotherapy
Table Global Adoptive Cellular Immunotherapy and Revenue (Million USD) Market Split by Product Type
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Types in 2018
Figure TIL Picture
Figure LAK Picture
Figure CAR-T Picture
Figure TCR-T Picture
Figure CIK Picture
Figure NK Picture
Figure DC Picture
Figure Other Picture
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Application (2014-2024)
Figure Adoptive Cellular Immunotherapy Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Cancer Hospital Picture
Figure Centers for Disease Control and Prevention Picture
Figure Rehabilitation Center Picture
Figure Other Picture
Table Global Market Adoptive Cellular Immunotherapy Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc Basic Information, Manufacturing Base and Competitors
Table Amgen Inc Adoptive Cellular Immunotherapy Type and Applications
Table Amgen Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Autolus Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Type and Applications
Table Autolus Therapeutics Plc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Beijing Immunochina Medical Science & Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bellicum Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Type and Applications
Table Bellicum Pharmaceuticals Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Type and Applications
Table Bristol-Myers Squibb Co Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table bluebird bio Inc Adoptive Cellular Immunotherapy Type and Applications
Table bluebird bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table CARsgen Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Type and Applications
Table CARsgen Therapeutics Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corp Basic Information, Manufacturing Base and Competitors
Table Celgene Corp Adoptive Cellular Immunotherapy Type and Applications
Table Celgene Corp Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cell Medica Ltd Basic Information, Manufacturing Base and Competitors
Table Cell Medica Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Cell Medica Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Cellular Biomedicine Group Inc Basic Information, Manufacturing Base and Competitors
Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Type and Applications
Table Cellular Biomedicine Group Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celularity Inc Basic Information, Manufacturing Base and Competitors
Table Celularity Inc Adoptive Cellular Immunotherapy Type and Applications
Table Celularity Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Celyad SA Basic Information, Manufacturing Base and Competitors
Table Celyad SA Adoptive Cellular Immunotherapy Type and Applications
Table Celyad SA Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Daiichi Sankyo Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Fosun Pharmaceutical AG Basic Information, Manufacturing Base and Competitors
Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Type and Applications
Table Fosun Pharmaceutical AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Type and Applications
Table Gilead Sciences Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hangzhou Converd Co Ltd Basic Information, Manufacturing Base and Competitors
Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Hangzhou Converd Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Manufacturing Base and Competitors
Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table HRAIN Biotechnology Co Ltd Basic Information, Manufacturing Base and Competitors
Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table HRAIN Biotechnology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Juno Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Type and Applications
Table Juno Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Kite Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Kite Pharma Inc Adoptive Cellular Immunotherapy Type and Applications
Table Kite Pharma Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nanjing Legend Biotech Co Ltd Basic Information, Manufacturing Base and Competitors
Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Nanjing Legend Biotech Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table NantKwest Inc Basic Information, Manufacturing Base and Competitors
Table NantKwest Inc Adoptive Cellular Immunotherapy Type and Applications
Table NantKwest Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Nkarta Inc Basic Information, Manufacturing Base and Competitors
Table Nkarta Inc Adoptive Cellular Immunotherapy Type and Applications
Table Nkarta Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Adoptive Cellular Immunotherapy Type and Applications
Table Novartis AG Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Ono Pharmaceutical Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Manufacturing Base and Competitors
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Type and Applications
Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Sorrento Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Type and Applications
Table Sorrento Therapeutics Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Takara Bio Inc Basic Information, Manufacturing Base and Competitors
Table Takara Bio Inc Adoptive Cellular Immunotherapy Type and Applications
Table Takara Bio Inc Adoptive Cellular Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Players (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Players (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Players in 2017
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Players in 2018
Figure Global Top 5 Players Adoptive Cellular Immunotherapy Revenue Market Share in 2018
Figure Global Top 10 Players Adoptive Cellular Immunotherapy Revenue Market Share in 2018
Figure Global Adoptive Cellular Immunotherapy Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Regions (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Market Share by Regions in 2018
Figure North America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table North America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
Table North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure North America Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure USA Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Canada Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Mexico Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Europe Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Europe Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Germany Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UK Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure France Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Russia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Italy Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure China Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Japan Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Korea Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure India Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table South America Adoptive Cellular Immunotherapy Revenue by Countries (2014-2019)
Table South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure South America Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Brazil Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Argentina Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Colombia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Adoptive Cellular Immunotherapy Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adoptive Cellular Immunotherapy Revenue Market Share by Countries in 2018
Figure Saudi Arabia Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure UAE Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Egypt Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure Nigeria Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Figure South Africa Adoptive Cellular Immunotherapy Revenue and Growth Rate (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue (Million USD) by Type (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Type (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Type in 2018
Table Global Adoptive Cellular Immunotherapy Revenue Forecast by Type (2019-2024)
Figure Global Adoptive Cellular Immunotherapy Market Share Forecast by Type (2019-2024)
Figure Global TIL Revenue Growth Rate (2014-2019)
Figure Global LAK Revenue Growth Rate (2014-2019)
Figure Global CAR-T Revenue Growth Rate (2014-2019)
Figure Global TCR-T Revenue Growth Rate (2014-2019)
Figure Global CIK Revenue Growth Rate (2014-2019)
Figure Global NK Revenue Growth Rate (2014-2019)
Figure Global DC Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue by Application (2014-2019)
Table Global Adoptive Cellular Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Application (2014-2019)
Figure Global Adoptive Cellular Immunotherapy Revenue Share by Application in 2018
Table Global Adoptive Cellul

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs